Jan 24, 2018

SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV

Journal of Immunology Research
Gracia Viviana Gonzalez-EnriquezBlanca Miriam Torres-Mendoza

Abstract

The serine incorporator 5 (SERINC5) is a recently discovered restriction factor that inhibits viral infectivity by preventing fusion. Retroviruses have developed strategies to counteract the action of SERINC5, such as the expression of proteins like negative regulatory factor (Nef), S2, and glycosylated Gag (glycoGag). These accessory proteins downregulate SERINC5 from the plasma membrane for subsequent degradation in the lysosomes. The observed variability in the action of SERINC5 suggests the participation of other elements like the envelope glycoprotein (Env) that modulates susceptibility of the virus towards SERINC5. The exact mechanism by which SERINC5 inhibits viral fusion has not yet been determined, although it has been proposed that it increases the sensitivity of the Env by exposing regions which are recognized by neutralizing antibodies. More studies are needed to understand the role of SERINC5 and to assess its utility as a therapeutic strategy.

  • References82
  • Citations2

Citations

Mentioned in this Paper

Neutralising Antibodies Analysis
Study
Immune Response
Subfamily lentivirinae
Lysosome Assembly Pathway
T-Lymphocyte
DNM1
Tissue Membrane
Pathogenicity
Carboxy-Terminal Amino Acid

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.